Researchers are exploring a potential weakness in tumors, referred to as the "Achilles heel," which may be related to a cell death mechanism. This vulnerability, associated with SLC7A11, could be exploited to develop new cancer treatment strategies, possibly by disrupting glutamine metabolism or targeting ferroptosis. The approach is being studied as a potential treatment for various types of cancer, including breast cancer.